PLAY PODCASTS
Breast Cancer Update

Breast Cancer Update

This series bridges the gap between research and patient care by providing on-going access to the perspectives and opinions of national and international breast cancer research leaders.

Dr. Neil Love

119 episodesEN

Show overview

Breast Cancer Update has been publishing since 2023, and across the 3 years since has built a catalogue of 119 episodes. That works out to roughly 120 hours of audio in total. Releases follow a fortnightly cadence, with the show now in its 25th season.

Episodes typically run thirty-five to sixty minutes — most land between 46 min and 1h 16m — though episode length varies meaningfully from one episode to the next. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Science show.

The show is actively publishing — the most recent episode landed 2 weeks ago, with 32 episodes already out so far this year. The busiest year was 2025, with 48 episodes published. Published by Dr. Neil Love.

Episodes
119
Running
2023–2026 · 3y
Median length
59 min
Cadence
Fortnightly

From the publisher

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology-oncology fellows ongoing access to the perspectives and opinions of national and international breast cancer clinical investigators.

Latest Episodes

View all 119 episodes

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 2 with Dr David W Cescon

Sep 22, 202623 min

Metastatic Triple-Negative Breast Cancer — 5-Minute Journal Club Activity 1 with Dr David W Cescon

Sep 21, 202629 min

Breast Cancer — Reviewing Key Presentations from the 2026 ASCO Annual Meeting

Sep 15, 20261h 29m

ER-Positive, HER2-Positive Metastatic Breast Cancer — Patterns of Care Among Community Oncologists

Sep 3, 202658 min

Metastatic Triple-Negative Breast Cancer — Patterns of Care

Aug 28, 20261h 2m

HR-Positive Metastatic Breast Cancer — Year in Review Series on Relevant New Datasets and Advances in the PI3K/AKT/mTOR Pathway

Aug 24, 202658 min

For Oncology Nurses: Oral Selective Estrogen Receptor Degraders in Breast Cancer — Proceedings from the 2026 Annual ONS Congress

Aug 18, 20261h 27m

For Oncology Nurses: Targeting the PI3K/AKT/mTOR Pathway in HR-Positive Metastatic Breast Cancer — Proceedings from the 2026 Annual ONS Congress

Aug 10, 20261h 29m

For Oncology Nurses: CDK4/6 Inhibitors for Breast Cancer — Proceedings from the 2026 Annual ONS Congress

Jul 29, 20261h 29m

Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting on the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway

Jul 25, 20261h 58m

HER2-Positive Metastatic Breast Cancer — An Interview with Prof Dr Sibylle Loibl on First-Line and Maintenance Therapy

Jul 18, 202646 min

Localized HR-Positive Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Jul 13, 202658 min

For Oncology Nurses: Strategies to Safely and Effectively Implement Antibody-Drug Conjugates — Proceedings from the 2026 Annual ONS Congress

Jul 10, 20261h 28m

Antibody-Drug Conjugates in the Management of Breast Cancer — Proceedings from a Session Held in Conjunction with the 2026 ASCO Annual Meeting

Jul 8, 20262h 0m

HR-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

Jun 29, 20261h 39m

Metastatic Triple-Negative Breast Cancer — What Clinicians Want to Know

Jun 26, 202653 min

HER2-Positive Breast Cancer — Fifth Annual National General Medical Oncology Summit

Jun 23, 202652 min

Desmoid Tumors — Microlearning Activity 4 with Prof Bernd Kasper

Jun 22, 202623 min

Triple-Negative Breast Cancer — Fifth Annual National General Medical Oncology Summit

Jun 20, 202649 min

HR-Positive Metastatic Breast Cancer — A Discussion and Debate on First- and Second-Line Therapy

Jun 11, 202658 min
Copyright 2025 Research To Practice. All Rights Reserved